C. Valero

515 total citations
8 papers, 117 citations indexed

About

C. Valero is a scholar working on Pathology and Forensic Medicine, Molecular Biology and Neurology. According to data from OpenAlex, C. Valero has authored 8 papers receiving a total of 117 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 2 papers in Molecular Biology and 2 papers in Neurology. Recurrent topics in C. Valero's work include Multiple Sclerosis Research Studies (5 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper). C. Valero is often cited by papers focused on Multiple Sclerosis Research Studies (5 papers), Radiomics and Machine Learning in Medical Imaging (1 paper) and Fibromyalgia and Chronic Fatigue Syndrome Research (1 paper). C. Valero collaborates with scholars based in Spain and United States. C. Valero's co-authors include Bonaventura Casanova, Francisco Coret, Bernardo Celda, Ana Pascual, Luís Bataller, Isabel Boscá, Lamberto Landete, Anis K. Mir, Ana María Jiménez Pascual and Luis Martí‐Bonmatí and has published in prestigious journals such as Neurology, Movement Disorders and Journal of Neurology.

In The Last Decade

C. Valero

7 papers receiving 114 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Valero Spain 5 84 50 23 19 16 8 117
Frédéric Pinna France 4 76 0.9× 52 1.0× 11 0.5× 18 0.9× 20 1.3× 6 126
Gioacchino Tedeschi Italy 3 123 1.5× 29 0.6× 9 0.4× 28 1.5× 19 1.2× 4 152
Nathalie Derache France 6 109 1.3× 75 1.5× 20 0.9× 36 1.9× 24 1.5× 18 173
Elio Prestipino Italy 9 137 1.6× 60 1.2× 11 0.5× 28 1.5× 17 1.1× 15 196
Rhian Raftopoulos United Kingdom 4 111 1.3× 61 1.2× 9 0.4× 36 1.9× 30 1.9× 4 171
Raffaello Bonacchi Italy 8 95 1.1× 27 0.5× 43 1.9× 40 2.1× 19 1.2× 15 155
Angelo Bellinvia Italy 8 147 1.8× 52 1.0× 10 0.4× 31 1.6× 16 1.0× 16 191
Alessandro Cagol Switzerland 8 142 1.7× 52 1.0× 25 1.1× 31 1.6× 20 1.3× 25 198
Gina Kirkish United States 7 84 1.0× 18 0.4× 14 0.6× 15 0.8× 17 1.1× 7 121
Hirohiko Ono Japan 6 78 0.9× 65 1.3× 15 0.7× 12 0.6× 26 1.6× 13 150

Countries citing papers authored by C. Valero

Since Specialization
Citations

This map shows the geographic impact of C. Valero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Valero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Valero more than expected).

Fields of papers citing papers by C. Valero

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Valero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Valero. The network helps show where C. Valero may publish in the future.

Co-authorship network of co-authors of C. Valero

This figure shows the co-authorship network connecting the top 25 collaborators of C. Valero. A scholar is included among the top collaborators of C. Valero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Valero. C. Valero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Valero, C., et al.. (2025). Deep learning in neurosurgery: a systematic literature review with a structured analysis of applications across subspecialties. Frontiers in Neurology. 16. 1532398–1532398. 1 indexed citations
2.
Valero, C., et al.. (2019). The syndrome of irreversible lithium-effectuated neurotoxicity (silent): A case report. European Neuropsychopharmacology. 29. S549–S549.
3.
Boscá, Isabel, et al.. (2008). Effect of relapses over early progression of disability in multiple sclerosis patients treated with beta-interferon. Multiple Sclerosis Journal. 14(5). 636–639. 18 indexed citations
4.
Pascual, Ana María Jiménez, M. Carmen Martínez‐Bisbal, Isabel Boscá, et al.. (2007). Axonal loss is progressive and partly dissociated from lesion load in early multiple sclerosis. Neurology. 69(1). 63–67. 29 indexed citations
5.
Casanova, Bonaventura, et al.. (2003). Evidence of Wallerian degeneration in normal appearing white matter in the early stages of relapsing-remitting multiple sclerosis. Journal of Neurology. 250(1). 22–28. 42 indexed citations
6.
Casanova, Bonaventura, Francisco Coret, C. Valero, et al.. (2002). High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study. Multiple Sclerosis Journal. 8(1_suppl). 59–63. 2 indexed citations
7.
Casanova, Bonaventura, Francisco Coret, C. Valero, et al.. (2002). High clinical inflammatory activity prior to the development of secondary progression: a prospective 5-year follow-up study. Multiple Sclerosis Journal. 8(1). 59–63. 9 indexed citations
8.
Bataller, Luís, et al.. (2001). Action hand dystonia after cortical parietal infarction. Movement Disorders. 16(6). 1183–1185. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026